Phototherapy-related ophthalmologic disorders

Clinics in Dermatology

Volumn 33, Issue 2, 2015, Pages 247-255

  DePry, Jennifer ^a   Brescoll, Jennifer ^b   Szczotka Flynn, Loretta ^c   Rambhatla, Pranita ^d   Lim, Henry W ^d   Cooper, Kevin ^a,e  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN; PYRIMIDINE DIMER; TANNIN DERIVATIVE; VERTEPORFIN;

ARTICLE; BASEMENT MEMBRANE; BLURRED VISION; CATARACT; CONJUNCTIVA; CORNEA; DESCEMET MEMBRANE; DRUG PULSE THERAPY; DRUG SENSITIVITY; EAR PROTECTIVE DEVICE; ENDOTHELIUM; EPITHELIUM CELL; ERYTHEMA; EYE DISEASE; EYE PROTECTION; EYELID CLOSURE; HEADACHE; HERPES SIMPLEX; HUMAN; INJECTION SITE REACTION; KERATITIS; KERATOPATHY; LACRIMATION; LENS; NAUSEA; NONHUMAN; ORAL BLISTER; PHOTOAGING; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOPHOBIA; PHOTOSENSITIVITY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE; RADIATION EXPOSURE; SKIN CANCER; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VIRUS REACTIVATION; VISUAL DISORDER; VOMITING; XEROSIS; ADVERSE EFFECTS; EYE DISEASES; EYE PROTECTIVE DEVICE; FEMALE; MALE; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; PROGNOSIS; PSORIASIS; RISK ASSESSMENT; SKIN DISEASES; UTILIZATION;

EYE DISEASES; EYE PROTECTIVE DEVICES; FEMALE; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PROGNOSIS; PSORIASIS; RISK ASSESSMENT; SKIN DISEASES; ULTRAVIOLET THERAPY;

EID: 84923841766     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2014.10.017     Document Type: Article

References (71)

1. Honigsmann H. History of phototherapy in dermatology. Photochem Photobiol Sci 2013, 12:16-21.
2. Goeckerman W.H. The treatment of psoriais. Northwest Med 1925, 24:229-231.
3. Parrish J.A., Fitzpatrick T.B., Tanenbaum L., et al. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974, 291:1207-1211.
4. Parrish J.A., Jaenicke K.F. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981, 76:359-362.
5. Yam J.C., Kwok A.K. Ultraviolet light and ocular diseases. Int Ophthalmol 2014, 34:383-400.
6. Archier E., Devaux S., Castela E., et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review. J Eur Acad Dermatol Venereol 2012, 26(Suppl. 3):22-31.
7. Mallet J.D., Rochette P.J. Wavelength-dependent ultraviolet induction of cyclobutane pyrimidine dimers in the human cornea. Photochem Photobiol Sci 2013, 12:1310-1318.
8. Mallet J.D., Rochette P.J. Ultraviolet light-induced cyclobutane pyrimidine dimers in rabbit eyes. Photochem Photobiol 2011, 87:1363-1368.
9. Gao N., Hu L.W., Gao Q., et al. Diurnal variation of ocular exposure to solar ultraviolet radiation based on data from a manikin head. Photochem Photobiol 2012, 88:736-743.
10. DePry J., Golding R., Szczotka-Flynn L., et al. UVB-protective properties of contact lenses with intended use in photoresponsive eyelid dermatoses. Photodermatol Photoimmunol Photomed 2013, 29:253-260.
11. Prystowsky J.H., Keen M.S., Rabinowitz A.D., et al. Present status of eyelid phototherapy. Clinical efficacy and transmittance of ultraviolet and visible radiation through human eyelids. J Am Acad Dermatol 1992, 26:607-613.
12. Chandler H.L., Reuter K.S., Sinnott L.T., et al. Prevention of UV-induced damage to the anterior segment using class I UV-absorbing hydrogel contact lenses. Invest Ophthalmol Vis Sci 2010, 51:172-178.
13. Pitts D.G. Ocular effects of radiant energy. Environment Vision: Interactions of the Eye, Vision and the Environment 1993, 151-220. Butterworth Heinemann, Stoneham, MA. D.G. Pitts, R.N. Kleinstein (Eds.).
14. Cullen A.P., Perera S.C. Sunlight and the human conjunctival action spectrum. Society of Photo-Optical Instrumentation Engineers Conference Series 1994, 24-30.
15. Pitts D.G. The human ultraviolet action spectrum. Am J Optom Physiol Opt 1974, 51:946-960.
16. Moore L., Hussey M., Ferreira J., et al. Review of photokeratitis: Corneal response to ultraviolet radiation (UVR) exposure. S Afr Optom 2010, 69:123-131.
17. Pitts D.G. Principles of ocular protection. Environment Vision: Interactions of the Eye, Vision and the Environment 1993, 259-280. Butterworth Heinemann, Stoneham, MA. D.G. Pitts, R.N. Kleinstein (Eds.).
18. American Conference of Governmental Industrial Hygienists. Ultraviolet Radiation. Documentation of the Threshold Limit Values and Biological Exposure Indices 2001, 4.
19. Quesnel N.M., Simonet P. Spectral transmittance of UV-absorbing soft and rigid gas permeable contact lenses. Optom Vis Sci 1995, 72:2-10.
20. Pitts D.G. The ocular ultraviolet action spectrum and protection criteria. Health Phys 1973, 25:559-566.
21. Pitts D.G., Cullen A.P., Hacker P.D. Ocular effects of ultraviolet radiation from 295 to 365 nm. Invest Ophthalmol Vis Sci 1977, 16:932-939.
22. Pitts D.G., Cullen A.P. Ocular ultraviolet effects from 295 nm to 400 nm in the rabbit. I: National Institute for Occupational Safety and Health Department of Health Education and Welfare 1977, 77-175.
23. Pitts D.G. Prescription absorptive lenses. Borish's Clinical Refraction 2006, 1177-1198. Butterworth Hinemann/Elsevier. W.J. Benjamin (Ed.).
24. Andley U.P., Lewis R.M., Reddan J.R., et al. Action spectrum for cytotoxicity in the UVA- and UVB-wavelength region in cultured lens epithelial cells. Invest Ophthalmol Vis Sci 1994, 35:367-373.
25. Zigman S. Ocular light damage. Photochem Photobiol 1993, 57:1060-1068.
26. Kinsey V.E. Spectral transmission of the eye to ultraviolet radiations. Arch Ophthalmol 1948, 39:508-513.
27. Podskochy A., Gan L., Fagerholm P. Apoptosis in UV-exposed rabbit corneas. Cornea 2000, 19:99-103.
28. Pitts D.G., Prince J.E., Butcher W.I., et al. The effects of ultraviolet radiation on the eye. Technical Report SAM-TR-69-10. USAF School of. Aerosp Med 1969, 1-120.
29. Cullen A.P. Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int J Toxicol 2002, 21:455-464.
30. Cejkova J., Stipek S., Crkovska J., et al. UV rays, the prooxidant/antioxidant imbalance in the cornea and oxidative eye damage. Physiol Res 2004, 53:1-10.
31. Schein O.D. Phototoxicity and the cornea. J Natl Med Assoc 1992, 84:579-583.
32. Verhoeff Bell L., Walker C.B. The pathologic effects of radiant energy on the eye: An experimental investigation with a systematic review on the literature. Proc Am Acad Arts Sci 1916, 51:630-818.
33. Sliney D.H. Physical factors in cataractogenesis: Ambient ultraviolet radiation and temperature. Invest Ophthalmol Vis Sci 1986, 27:781-790.
34. Chao S.C., Hu D.N., Yang P.Y., et al. Ultraviolet-A irradiation upregulated urokinase-type plasminogen activator in pterygium fibroblasts through ERK and JNK pathways. Invest Ophthalmol Vis Sci 2013, 54:999-1007.
35. Di Girolamo N., Kumar R.K., Coroneo M.T., et al. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002, 43:3430-3437.
36. Dillon J. UV-B as a pro-aging and pro-cataract factor. Doc Ophthalmol 1994, 88:339-344.
37. Pitts D.G. Ultraviolet-absorbing spectacle lenses, contact lenses, and intraocular lenses. Optom Vis Sci 1990, 67:435-440.
38. Taylor H.R., West S.K., Rosenthal F.S., et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988, 319:1429-1433.
39. Otman S.G., El-Dars L.D., Edwards C., et al. Eye protection for ultraviolet B phototherapy and psoralen ultraviolet A patients. Photodermatol Photoimmunol Photomed 2010, 26:143-150.
40. Schmidt R.E., Zuclich J.A. Retinal lesions due to ultraviolet laser exposure. Invest Ophthalmol Vis Sci 1980, 19:1166-1175.
41. Mainster M.A., Turner P.L. Ultraviolet-B phototoxicity and hypothetical photomelanomagenesis: Intraocular and crystalline lens photoprotection. Am J Ophthalmol 2010, 149:543-549.
42. Boettner E.A., Wolter J.R. Transmission of the ocular media. Invest Ophthalmol Vis Sci 1962, 1:776-783.
43. Drucker A.M., Rosen C.F. Drug-induced photosensitivity: Culprit drugs, management and prevention. Drug Saf 2011, 34:821-837.
44. Wren V. Ocular & visual side effects of systemic drugs: Clinically relevant toxicology and patient management. J Behav Optom 2000, 11:149-157.
45. Anthony F.A., Laboda H.M., Costlow M.E. Psoralen-fatty acid adducts activate melanocyte protein kinase C: A proposed mechanism for melanogenesis induced by 8-methoxypsoralen and ultraviolet A light. Photodermatol Photoimmunol Photomed 1997, 13:9-16.
46. Wolff K. Side-effects of psoralen photochemotherapy (PUVA). Br J Dermatol 1990, 122(Suppl. 36):117-125.
47. Calzavara-Pinton P.G., Carlino A., Manfredi E., et al. Ocular side effects of PUVA-treated patients refusing eye sun protection. Acta Derm Venereol Suppl 1994, 186:164-165.
48. Barker F.M., Dayhaw-Barker P., Forbes P.D., et al. Ocular effects of treatment with various psoralen derivatives and ultraviolet-A (UVA) radiation in HRA/Skh hairless mice. Acta Ophthalmol 1986, 64:471-478.
49. Malanos D., Stern R.S. Psoralen plus ultraviolet A does not increase the risk of cataracts: A 25-year prospective study. J Am Acad Dermatol 2007, 57:231-237.
50. Abdullah A.N., Keczkes K. Cutaneous and ocular side-effects of PUVA photochemotherapy-a 10-year follow-up study. Clin Exp Dermatol 1989, 14:421-424.
51. Archier E., Devaux S., Castela E., et al. Ocular damage in patients with psoriasis treated by psoralen UV-A therapy or narrow band UVB therapy: A systematic literature review. J Eur Acad Dermatol Venereol 2012, 26(Suppl. 3):32-35.
52. Mennel S., Barbazetto I., Meyer C.H., et al. Ocular photodynamic therapy-standard applications and new indications (part 1). Review of the literature and personal experience. Ophthalmologica 2007, 221:216-226.
53. Chiou J.F., Wang Y.H., Jou M.J., et al. Verteporfin-photoinduced apoptosis in HepG2 cells mediated by reactive oxygen and nitrogen species intermediates. Free Radic Res 2010, 44:155-170.
54. Ammar D.A., Kahook M.Y. In vitro effects of verteporfin on ocular cells. Mol Vis 2013, 19:424-429.
55. Javey G., Schwartz S.G., Albini T.A. Ocular complication of intense pulsed light therapy: Iris photoablation. Dermatol Surg 2010, 36:1466-1468.
56. Lee W.W., Murdock J., Albini T.A., et al. Ocular damage secondary to intense pulse light therapy to the face. Ophthal Plast Reconstr Surg 2011, 27:263-265.
57. Town G., Ash C. Are home-use intense pulsed light (IPL) devices safe?. Lasers Med Sci 2010, 25:773-780.
58. Guy G.P., Berkowitz Z., Watson M., et al. Indoor tanning among young non-Hispanic white females. JAMA Intern Med 2013, 173:1920-1922.
59. Lazovich D., Vogel R.I., Berwick M., et al. Indoor tanning and risk of melanoma: A case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010, 19:1557-1568.
60. Watson M., Holman D.M., Fox K.A., et al. Preventing skin cancer through reduction of indoor tanning: Current evidence. Am J Prev Med 2013, 44:682-689.
61. International Agency for Research of Cancer Working Group Exposure to artificial UV radiation and skin cancer 2006, 1-64. World Health Organization International Agency for Resarch of Cancer.
62. De Winter S., Pavel S. Tanning beds: Effect on skin cancer risk unclear. Ned Tijdschr Geneeskd 2000, 144:467-470. [Dutch].
63. Zhang M., Qureshi A.A., Geller A.C., et al. Use of tanning beds and incidence of skin cancer. J Clin Oncol 2012, 30:1588-1593.
64. Boniol M., Autier P., Boyle P., et al. Cutaneous melanoma attributable to sunbed use: Systematic review and meta-analysis. Br Med J 2012, 345:e4757.
65. International Agency for Research on Cancer Working Group on artificial ultraviolet light, skin cancer The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer 2007, 120:1116-1122.
66. Nikolaou V., Stratigos A.J. Emerging trends in the epidemiology of melanoma. Br J Dermatol 2014, 170:11-19.
67. Spencer J.M., Amonette R. Tanning beds and skin cancer: Artificial sun + old sol = real risk. Clin Dermatol 1998, 16:487-501.
68. Vajdic C.M., Kricker A., Giblin M., et al. Artificial ultraviolet radiation and ocular melanoma in Australia. Int J Cancer 2004, 112:896-900.
69. Almutawa F., Vandal R., Wang S.Q., et al. Current status of photoprotection by window glass, automobile glass, window films, and sunglasses. Photodermatol Photoimmunol Photomed 2013, 29:65-72.
70. Walsh J.E., Koehler L.V., Fleming D.P., et al. Novel method for determining hydrogel and silicone hydrogel contact lens transmission curves and their spatially specific ultraviolet radiation protection factors. Eye Contact Lens 2007, 33:58-64.
71. Giblin F.J., Lin L.R., Leverenz V.R., et al. A class I (Senofilcon A) soft contact lens prevents UVB-induced ocular effects, including cataract, in the rabbit in vivo. Invest Ophthalmol Vis Sci 2011, 52:3667-3675.